Particle accelerators are a key asset of the European Research Area. Their use spans from the large installations devoted to fundamental science to a wealth of facilities providing X-ray or neutron beams to a wide range of scientific disciplines. Beyond scientific laboratories, their use in medicine and industry is rapidly growing. Notwithstanding their high level of maturity, particle accelerators are now facing critical challenges related to the size and performance of the facilities envisaged for the next step of particle physics research, to the increasing demands to accelerators for applied science, and to the specific needs of societal applications. In this crucial moment for accelerator evolution, I.FAST aims at enhancing innovation in and from accelerator-based Research Infrastructures (RI) by developing innovative breakthrough technologies common to multiple accelerator platforms, and by defining strategic roadmaps for future developments. I.FAST will focus the technological R&D on long-term sustainability of accelerator-based research, with the goal of developing more performant and affordable technologies, and of reducing power consumption and impact of accelerator facilities, thus paving the way to a sustainable next-generation of accelerators. By involving industry as a co-innovation partner via the 17 industrial companies in the Consortium, 12 of which SME’s, I.FASTwill generate and maintain an innovation ecosystem around the accelerator-based RIs that will sustain the long-term evolution of accelerator technologies in Europe. To achieve its goals, I.FAST will explore new alternative accelerator concepts and promote advanced prototyping of key technologies. These include, among others, techniques to increase brightness and reduce dimensions of synchrotron light sources, advanced superconducting technologies to produce higher fields with lower consumption, and strategies and technologies to improve energy efficiency.

There is an increasing demand for advanced materials with temperature capability in highly corrosive environments for aerospace. Rocket nozzles of solid/hybrid rocket motors must survive harsh thermochemical and mechanical environments produced by high performance solid propellants (2700-3500°C). Thermal protection systems (TPS) for space vehicles flying at Mach 7 must withstand projected service temperatures up to 2500°C associated to convective heat fluxes up to 15 MWm-2 and intense mechanical vibrations at launch and re-entry into Earth’s atmosphere. The combination of extremely hot temperatures, chemically aggressive environments and rapid heating/cooling is beyond the capabilities of current materials. Main purpose of C3HARME is to design, develop, manufacture, test and validate a new class of out-performing, reliable, cost-effective and scalable Ultra High Temperature Ceramic Matrix Composites (UHTCMCs) based on C or SiC fibres/preforms enriched with ultra-high temperature ceramics (UHTCs) capable o

Nanoker Research, S.L has identified a potential business in dNanoker Research, S.L has identified a potential business in developing and promoting global dental solutions of the highest quality for patients with periodontal or peri-implant disease, which is the most prevalent form of bone pathology in humans, affecting 50% of the entire adult population. Nanoker has developed an aesthetic, mechanically reliable and tissue friendly all-ceramic dental reconstruction solution at TRL6 that prevents periimplantitis; in 2016, the global market value of dental implants and prosthetics reached 6.175 M€, with an estimated compound annual growth rate (CAGR) of 7-9% for the next few years. Nanoker has the potential to become the only company in the world with an available, long-lasting, non-invasive dental solution for periimplantitis patients. This solution is expected to obtain around 0.49% of the dental implant market share 3 years after project termination, and around 1.13% (133 M€) of the dental implant market share 5 years later. Thus, in only four years, Nanoker could reach a turnover of +47.3 M€ with a production capability of 100,000 implants-abutments/year and an accumulated EBITDA of +33.9 M€ (over four years). To remove the last dental health market barriers it is necessary to make a final investment in terms of product industrialization and certification, as described in this proposal, to become known and worthy to key opinion leaders. In this regard, this project, with a total budget of 4,370,373.75 € covers the expenses related to: a) the successful industrial-scale development of a set of dental prosthetic components made from a coated and highly resistant ceramic nanocomposite; b) performing a Clinical Validation; c) business growth, through two different distribution approaches: an own firm and implant manufacturers with presence in the main markets; and d) the product’s worldwide launch, to put Nanoker at the forefront of the market and industry innovation.